Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26‐week PRONTO‐T1D study

por Klaff, Leslie, Cao, Dachuang, Dellva, Mary Anne, Tobian, Janet, Miura, Junnosuke, Dahl, Dominik, Lucas, Jean, Bue‐Valleskey, Juliana
Publicado 2020

Long-Term Efficacy and Safety of Ultra Rapid Lispro (URLi) in Adults with Type 1 Diabetes: The PRONTO-T1D Extension

por Bue-Valleskey, Juliana, Klaff, Leslie, Cho, Jang Ik, Dellva, Mary Anne, Schloot, Nanette C., Tobian, Janet, Miura, Junnosuke, Dahl, Dominik
Publicado 2021

Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO‐Pump‐2

por Warren, Mark, Bode, Bruce, Cho, Jang I., Liu, Rong, Tobian, Janet, Hardy, Thomas, Chigutsa, Farai, Phillip, Moshe, Horowitz, Barry, Ignaut, Debra
Publicado 2021